ALMKT:EPA
Mauna Kea Technologies SA
€ ०.०९२
०.००%
(०.००) 1D
नोभेम्बर १३, १७:३५:०१ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€ ०.०९
High
€ ०.१०
Low
€ ०.०९
Mkt. cap
१.८१ करोड
Avg. vol.
५.४१ लाख
Volume
७५.१६ हजार
P/E ratio
०.७९
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५६
Open
€ ०.०९
High
€ ०.१०
Low
€ ०.०९
Mkt. cap
१.८१ करोड
Avg. vol.
५.४१ लाख
Volume
७५.१६ हजार
P/E ratio
०.७९
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५६
News stories
From web sources and news partners
TradingKey
·
४ घण्टा पहिले
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
४ घण्टा पहिले
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
TradingView
·
१२ घण्टा पहिले
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
११ घण्टा पहिले
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees५६
Founded२०००
Headquarters-
SectorHealth Care
Industry-
Websitemaunakeatech.com